ClinConnect ClinConnect Logo
Search / Trial NCT01685658

Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Sep 12, 2012

Trial Information

Current as of June 07, 2025

Withdrawn

Keywords

ClinConnect Summary

The secondary objectives of this study are:

* To compare the efficacy (non-inferiority) of intravenous paracetamol and ketoprofen at 90 minutes (vns for pain).
* To compare both arms in terms of other administered drugs (for pain).
* To observe and compare side effects between the two arms: cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine.
* To determine predictors for the use of intravenous morphine when treating renal colic.
* To compare hospitalization rates betwe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for a telephone interview at week 1
  • Patient consulting at the Nîmes University Hospital emergency ward with suspicion of renal colic
  • Exclusion Criteria:
  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • The patient has a contraindication for a treatment used in this study
  • The patient has an allergy to ketoprofen or paracetamol, a history of gastric or intestinal ulcers, bleeding disorders, history of asthma triggered by taking ketoprofen or substances with similar activity such as other NSAIDs or aspirin
  • The patient has a fever or is hemodynamically unstable, oligoanuria
  • The patient presents with an initial verbal numeric pain score of 10/10.
  • The patient has a history of aneurysm or aortic dissection, history of renal transplantation, history of renal or hepatic insufficiency
  • The patient took paracetamol or ketoprofen 4 hours before emergency treatment.

About Centre Hospitalier Universitaire De Nīmes

The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.

Locations

Alès, , France

Nîmes Cedex 9, , France

Patients applied

0 patients applied

Trial Officials

Pierre-Géraud Claret, MD

Principal Investigator

Centre Hospitalier Universitaire de Nîmes

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials